Equillium, Inc. Common Stock (EQ) is a publicly traded Healthcare sector company. As of October 26, 2026, EQ trades at $1.19 with a market cap of $77.99M and a P/E ratio of -3.58. EQ moved -2.44% today. Year to date, EQ is -20.65%; over the trailing twelve months it is -7.52%. Its 52-week range spans $0.27 to $3.54. Analyst consensus is strong buy with an average price target of $10.67. Rallies surfaces EQ's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
6 analysts cover EQ: 0 strong buy, 6 buy, 0 hold, 0 sell, and 0 strong sell. The consensus rating is strong buy. The average price target is $10.67.
| Metric | Value |
|---|---|
| Price | $1.19 |
| Market Cap | $77.99M |
| P/E Ratio | -3.58 |
| EPS | $-0.39 |
| Dividend Yield | 0.69% |
| 52-Week High | $3.54 |
| 52-Week Low | $0.27 |
| Volume | 34.32K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-22.40M |
| Gross Margin | 0.00% |
6 analysts cover EQ: 0 strong buy, 6 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $10.67.